Viewing Study NCT03326193


Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2026-03-02 @ 8:03 PM
Study NCT ID: NCT03326193
Status: COMPLETED
Last Update Posted: 2025-07-31
First Post: 2017-10-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Niraparib Combined With Bevacizumab Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
Sponsor: Tesaro, Inc.
Organization: